Regeneron Pharmaceuticals's chart data is dated 2026-10-08. There is no active technical signal. There are 7 published signal records.
Regeneron Pharmaceuticals last closed at $739.57 (-0.34%) on 2026-10-08. Listed on Nasdaq. Trailing 12 months PER is 18.2×. Its overall grade ranks 139 of 738 stocks in Healthcare.
About this company
Regeneron Pharmaceuticals last closed at $739.57 (-0.34%) on 2026-10-08. Listed on Nasdaq.
Details →Reported results
Position in sector
Healthcare · Overall A · 139/738
Valuation grade D
Dividends
2025 dividend per share · $3.52 · Yield 0.49%
Details →Related stocks
- SanofiCompetitor
아토피/면역질환 등 공동개발 후 사업 이해관계가 겹치는 주요 경쟁·협력사
- AstraZenecaCompetitor
호흡기·면역·안과 등 혁신 바이오 영역에서 직접 경쟁하는 글로벌 제약사
- NovartisCompetitor
안과·면역·희귀질환 치료제 분야에서 경쟁하는 대형 제약사
ETFs holding this stock
VanEck Biotech ETF · iShares Biotechnology ETF · Invesco Nasdaq Biotechnology ETF
Details →About Regeneron Pharmaceuticals
- What technical signals does Regeneron Pharmaceuticals (REGN) have?
- Regeneron Pharmaceuticals current technical signals: no active technical signal.
- Is Regeneron Pharmaceuticals a cup-and-handle pattern?
- No. Regeneron Pharmaceuticals has no valid Cup signal right now.
- What published figures are available for Regeneron Pharmaceuticals?
- Market cap: $78.02B. Trailing 12 months PER: 18.2×. Latest quarter PBR: 2.49×. Dividend yield: 0.49%.
Like these rules? Backtest them.
Run this signal on this ticker in the free backtest builder — same window, no install.
Backtest this rule ↗Major stocks in the same sector
2026-10-09 dataset
Turn what you saw on this name into a strategy
Ask Q about Regeneron Pharmaceuticals, or open the plan table on the main site.
From the names you found to a trading rule
Tell Q about the stocks you found to place orders with your conditions.